Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for ...

Quest Diagnostics (DGX) reports 12% Q1 2025 revenue growth, driven by acquisitions, partnerships, and advanced diagnostics.

U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Tuesday. Shares of Quest Diagnostics ...

We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we ...

GRAIL's groundbreaking Galleri test, detecting 50+ cancers, FDA status, and strategic growth make it a top investment with ...

Shares of Quest Diagnostics Inc. DGX slid 2.74% to $159.80 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.57% to ...

UBS Group lifted their price objective on shares of Quest Diagnostics from $166.00 to $170.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Finally ...

India’s stock markets remained volatile on Thursday, 3 April, as reciprocal tariffs imposed by US President Donald Trump added to the pressure from the weekly derivatives expiry. Sectors such as ...

Learn More » *Stock prices used were the afternoon prices ... if you invested $1,000 at the time of our recommendation, you’d have $676,774!* ...

India's stock markets have remained volatile over the past five trading sessions, facing resistance at the 50-week moving average, with Nifty 50 trading within the 23,800–23,100 range.